Native-RISE (Risk Identification for Suicide and Enhanced Care)

The goal of this research is to test a systems-level suicide prevention strategy, Native-RISE (Risk Identification for Suicide and Enhanced care), that combines predictive analytics and brief contact interventions (BCIs) to reduce suicide in health systems serving Native Americans (NAs). This project aims to prove the effectiveness and scalability of Native-RISE within three Indian Health Service (IHS) health care clinics (Whiteriver, Chinle and Shiprock) already implementing suicide prevention programs and serving the White Mountain Apache Tribe (WMAT) and Navajo Nation (NN).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

1687

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arizona
      • Chinle, Arizona, United States, 86503
        • Chinle Navajo Nation Center for Indigenous Health
      • Whiteriver, Arizona, United States, 85941
        • Whiteriver Center for Indigenous Health
    • New Mexico
      • Shiprock, New Mexico, United States, 87420
        • Shiprock Center for Indigenous Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged 18-75
  • Visit at least one of the three participating IHS clinics
  • Identified as at risk of suicide by either an existing method or the new Native-RISE risk model algorithm

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Case Managers WITH algorithm AND with provider risk notification (SI/SA/Binge/NSSI)
Case Managers who see the algorithm classification + IHS provider risk notification & resource card distribution. These participants present with suicide ideation (SI), suicide attempt (SA), binge substance use (Binge), or non-suicidal self injury (NSSI).
Case managers see the Native-RISE algorithm classification and Clinical Providers receive a risk notification. A resource card is provided to the participant.
Active Comparator: Case Managers withOUT algorithm AND with provider risk notification (SI/SA/Binge/NSSI)
Case Managers who do NOT see the algorithm classification + IHS provider risk notification & resource card distribution. These participants present with suicide ideation (SI), suicide attempt (SA), binge substance use (Binge), or non-suicidal self injury (NSSI).
Clinical Providers receive a risk notification and a resource card is provided to the participant.
Experimental: Case Managers WITH algorithm AND provider risk notification (high risk history, no SI/SA/Binge/NSSI
Case Managers who see the algorithm classification + provider risk notification; participants get resource card distribution. High risk participants based on algorithm classification.
Case managers see the Native-RISE algorithm classification and Clinical Providers receive a risk notification. A resource card is provided to the participant.
Active Comparator: Provider risk notification alone (high risk history, without SI/SA/Binge/NSSI)
Provider risk notification alone; participants get resource card distribution. High risk participants based on algorithm classification.
Clinical Providers receive a risk notification and a resource card is provided to the participant.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of suicide attempts among individuals flagged at elevated risk
Time Frame: 12 months
Rate of suicide attempts among individuals flagged at elevated risk is tracked through International Classification of Diseases (ICD) codes and chief complaints as recorded in the participating health system.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of contacts with Case Managers (Reach of Brief Contact Interventions (BCI))
Time Frame: 12 months
Reach of BCI is defined as at least three or more contacts with Case Managers within the first year following identification of elevated risk.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emily Haroz, PhD, Johns Hopkins University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2024

Primary Completion (Estimated)

September 30, 2028

Study Completion (Estimated)

December 31, 2028

Study Registration Dates

First Submitted

January 15, 2025

First Submitted That Met QC Criteria

January 15, 2025

First Posted (Actual)

January 20, 2025

Study Record Updates

Last Update Posted (Actual)

February 2, 2026

Last Update Submitted That Met QC Criteria

January 29, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • IRB00026145

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide Prevention

Clinical Trials on System of Care - combination of algorithm and Brief Contact Intervention

Subscribe